Person with glasses looking at paperwork.

The transition from the EU Clinical Trials Directive (CTD) to the new Clinical Trials Regulation (CTR) represents a major shift in how trials will be conducted across Europe. While this overhaul aims to streamline processes, navigating EU CTR is complex. We have distilled recommendations from the EU Clinical Trials Coordination and Advisory Group (CTAG) into actionable checklists to aid in planning, and our proposed workflow highlights steps to help sponsors navigate the transition process.

Related resources

Biopharma professional on laptop browsing Pink Sheet for global policy and regulatory insights.
MAY 01, 2022
eBook
Regulatory & Compliance

Your Keys to Understanding EU Transparency

A collection of Pink Sheet articles covering evolving EU regulations on clinical trial disclosure and transparency

Hands with a digital icon for security hovering above them.
SEP 01, 2023
White paper
Regulatory & Compliance

Clinical Trial Disclosure Compliance a Moving Target Due to Ever-changing Global Regulations

Gain insights on key factors driving disclosure rule updates and ways to minimize noncompliance risks.

HBW Insight podcast_resource-card-thumbnail
JUN 25, 2023
Podcast
Commercial

What You Need to Know About the EU Green Claims Directive

The Pharma R&D Annual Review 2023 Supplement looks at new active substances (NASs), drugs launched onto the market for the first time, during 2022